The Mechanics of Innovation: A Comprehensive Analysis of 830 CMR 63.38M.1 and the Massachusetts Research Credit

Regulation 830 CMR 63.38M.1 provides the procedural framework for business corporations to claim the Massachusetts Research Credit, ensuring that tax incentives for innovation are strictly tied to activities conducted within the Commonwealth. It translates the broad statutory language of M.G.L. c. 63, § 38M into specific requirements for identifying qualified expenses, calculating incremental increases in research spending, and managing tax credit carryforwards across multiple years. 1

The Massachusetts Research Credit represents a cornerstone of the Commonwealth’s economic policy, designed to foster a competitive environment for industries ranging from biotechnology and pharmaceuticals to defense and software development. 2 While the credit closely parallels the federal research credit available under Section 41 of the Internal Revenue Code (IRC), it possesses unique state-specific constraints, most notably a rigorous “geographic nexus” requirement that limits eligibility to expenditures incurred for research activity conducted physically within Massachusetts. 1 Since its inception in 1991, the regulatory environment surrounding this credit has evolved significantly, particularly with the 2014 introduction of the Alternative Simplified Method (ASM) and recent judicial expansions of eligible entity types. 3 For corporate tax directors and financial planners, navigating 830 CMR 63.38M.1 requires a nuanced understanding of how local administrative guidance from the Department of Revenue (DOR) interacts with federal standards to produce a state-level tax benefit that is both substantial and strictly governed. 3

The Statutory Foundation: M.G.L. c. 63, § 38M

To understand the regulation, one must first examine the enabling statute, Massachusetts General Law Chapter 63, Section 38M. This law establishes that a business corporation shall be allowed a credit against its excise due equal to the sum of 10% of the excess of qualified research expenses (QREs) over a base amount, plus 15% of basic research payments. 3 The statute serves as the primary authority, but it delegates significant power to the Commissioner of Revenue to promulgate regulations that define exactly how these amounts are computed, particularly for controlled groups and specialized industries. 3

The legislative intent behind § 38M was to stimulate high-wage job creation and capital investment by lowering the after-tax cost of research and development (R&D). 4 Unlike many other state credits, the Massachusetts Research Credit is largely non-refundable, meaning it can only offset tax liability rather than providing a direct cash payment, with the notable exception of certified life sciences companies. 2 This structure incentivizes companies to remain profitable within the state, as the value of the credit is realized through the reduction of corporate excise. 4

Table 1: Core Statutory Components of the Massachusetts Research Credit

The Regulatory Dualism: 830 CMR 63.38M.1 vs. 830 CMR 63.38M.2

A point of frequent confusion for practitioners is the relationship between the existing regulation (830 CMR 63.38M.1) and the proposed regulation (830 CMR 63.38M.2). 1 The original regulation, 830 CMR 63.38M.1, was written to provide guidance for tax years beginning on or after January 1, 1991. 3 However, the 2014 Economic Development Act significantly revised the research credit, introducing the Alternative Simplified Method and decoupling the Massachusetts “base amount” from the federal calculation. 7

To address these changes, the DOR issued “Proposed” Regulation 830 CMR 63.38M.2. 1 Although it remains in “proposed” status, the Department has explicitly directed taxpayers to follow its provisions for tax years beginning on or after January 1, 2015, through various Technical Information Releases (TIRs) and form instructions. 7 This creates a dual regulatory landscape where 830 CMR 63.38M.1 governs historical audits and foundational definitions, while the proposed.2 regulation dictates current calculation mechanics. 7

Decoupling from Federal Base Amounts

A critical shift introduced in the modern regulatory framework is the decoupling from the federal fixed-base percentage. 7 Prior to 2015, the Massachusetts base amount was heavily tied to a corporation’s research expenditures relative to gross receipts for a fixed five-year period (typically 1984–1988). 1 The new regulation allows for a rolling lookback period, which is more reflective of a company’s current business cycle and reduces the administrative burden of locating decades-old financial records. 1

Defining Massachusetts Qualified Research Expenses (QREs)

The definition of a QRE in Massachusetts is a strict subset of the federal definition. To be eligible, an expense must satisfy two conditions: it must be a qualified research expense under Section 41(b) of the Code, and it must have been incurred for research activity conducted in Massachusetts. 3 If an activity occurs across state lines, the expense must be meticulously prorated based on the ratio of days the service or property was used in the Commonwealth versus the total time employed. 5

The Categories of Eligible Costs

Regulation 830 CMR 63.38M.1(4) identifies four primary categories of costs that can constitute a Massachusetts QRE:

1. Wages: These include wages paid to employees for qualified services performed in Massachusetts. 1 “Qualified services” generally involve actually conducting research, as well as the direct supervision or direct support of research activities. 2
2. Supplies: This covers amounts paid for tangible property (other than land or improvements) used or consumed in Massachusetts during the research process. 1
3. Computer Fees: Payments for the right to use computers located in Massachusetts, provided the qualified research also takes place in the state. 1
4. Contract Research Expenses: Massachusetts allows 65% of amounts paid to third parties for research, provided the research activity is conducted at a facility located in Massachusetts. 1

Table 2: Comparative Analysis of Federal vs. Massachusetts QREs

Calculation Methodology: The Choice of Two Paths

For tax years beginning on or after January 1, 2015, corporations must choose between the “Traditional Method” and the “Alternative Simplified Method” (ASM). 7 This election is typically made on the original return and is binding for that year, though recent guidance has relaxed some of these constraints for specific situations like the financial institution expansion. 6

The Traditional Method (M.G.L. c. 63, § 38M(a))

The Traditional Method remains the most lucrative for established companies with a high volume of basic research payments and stable R&D-to-gross-receipts ratios. 2 The credit is calculated as 10% of the current year’s QREs that exceed a “base amount,” plus 15% of basic research payments. 3

The base amount under the Traditional Method is defined as the product of the “Massachusetts fixed-base ratio” and the average annual gross receipts for the four preceding years. 1 For years starting in 2015, the fixed-base ratio is determined by dividing average Massachusetts QREs for the third and fourth preceding years by the average annual gross receipts for those same two years, capped at 16%. 1

The Minimum Base Amount Rule

A critical protective measure for the Commonwealth is the “minimum base amount.” 1 Regardless of the fixed-base ratio, the base amount used in the calculation cannot be less than 50% of the current year’s QREs. 1 This ensures that even companies with very low historical research spending must significantly increase their investment to see a large credit, preventing the credit from becoming a windfall for “business as usual” activities. 1

The Alternative Simplified Method (M.G.L. c. 63, § 38M(b))

The ASM was introduced to simplify compliance for startups and companies with fluctuating gross receipts. 2 Unlike the Traditional Method, the ASM does not require gross receipts as a component. 4 Instead, it focuses solely on a three-year lookback of QREs. 14

For 2024 and beyond, the ASM credit is 10% of the current year’s QREs that exceed 50% of the average QREs from the three preceding years. 1 If a corporation did not have QREs in any one of those three years, the credit is a flat 5% of the current year’s QREs. 8 It is important to note that the ASM does not include an additional credit for basic research payments. 2

Table 3: Evolution of the Alternative Simplified Method (ASM) Rates

Local Revenue Office Guidance and Judicial Interpretations

The Massachusetts Department of Revenue (DOR) provides ongoing interpretation of 830 CMR 63.38M.1 through Technical Information Releases (TIRs). 15 These documents are vital for understanding how the state applies the law to emerging business practices and judicial rulings.

TIR 14-16: Technical Corrections and Phased-In Rates

Following the 2014 legislative changes, TIR 14-16 served as the definitive guide for the transition to the ASM. 13 It clarified that the 2014 Supplemental Budget had made technical corrections to ensure the credit rates were phased in properly, starting at 5% and reaching 10% by 2021. 13 This TIR also established the procedure for corporations with no research history, providing them with the flat 5% “safety net” credit. 15

TIR 25-3: The State Street Expansion

Perhaps the most significant change in the 30-year history of the credit occurred in 2024–2025. For decades, the DOR had maintained that only “business corporations” subject to the excise tax under M.G.L. c. 63, § 39 were eligible for the credit. 6 This effectively excluded financial institutions, which are taxed under § 2. 6

In the case of State Street Corporation v. Commissioner of Revenue, the Appellate Tax Board ruled that the statutory definition of “business corporation” was broad enough to include banks. 6 TIR 25-3 outlines the DOR’s reluctant acceptance of this ruling. 6 Following this decision, financial institutions are now permitted to claim the research credit, even on amended returns for prior years. 6 This represents a massive expansion of the credit’s fiscal impact and provides a major tax-saving opportunity for the state’s significant financial sector. 6

TIR 20-15: The Impact of Remote Work

The “conducted in Massachusetts” requirement of 830 CMR 63.38M.1 faced a unique challenge during the COVID-19 pandemic. 21 TIR 20-15 provided temporary guidance for companies whose employees were forced to work remotely from out-of-state locations due to government orders. 21 While primarily focused on nexus and withholding, this guidance underscored the DOR’s strict adherence to the physical presence rule once emergency orders were lifted. 21 For research credit purposes, this means that wages paid to remote employees living in New Hampshire or Rhode Island generally do not qualify as Massachusetts QREs, even if the company is based in Boston. 5

Practical Application: A Detailed Calculation Example

To illustrate the interplay of these rules, consider a hypothetical software company, “MassCode Inc.,” calculating its 2024 Research Credit.

Data for MassCode Inc.

• 2024 Massachusetts QREs: $5,000,000
• 2023 QREs: $4,000,000
• 2022 QREs: $3,500,000
• 2021 QREs: $3,000,000
• Average QREs (2021-2023): $3,500,000
• Average Annual Gross Receipts (2020-2023): $20,000,000
• Historical Fixed-Base Ratio: 6.5%

Option 1: The Traditional Method

1. Calculate Preliminary Base Amount:
   $Base = Fixed\ Base\ Ratio \times Avg\ Gross\ Receipts$
   $Base = 0.065 \times \$20,000,000 = \$1,300,000$ 2
2. Apply Minimum Base Amount Rule:
   $Minimum\ Base = 50\% \times Current\ Year\ QREs$
   $Minimum\ Base = 0.50 \times \$5,000,000 = \$2,500,000$ 1
3. Determine Actual Base:
   Since $2,500,000 is greater than $1,300,000, the base amount for the calculation is $2,500,000. 3
4. Calculate Credit:
   $Credit = 10\% \times (Current\ QREs – Base)$
   $Credit = 0.10 \times (\$5,000,000 – \$2,500,000) = \$250,000$ 3

Option 2: The Alternative Simplified Method (ASM)

1. Calculate Base (50% of 3-year Average):
   $Base = 50\% \times \$3,500,000 = \$1,750,000$ 2
2. Calculate Excess QREs:
   $Excess = \$5,000,000 – \$1,750,000 = \$3,250,000$ 16
3. Calculate Credit (using the 10% rate for 2024):
   $Credit = 10\% \times \$3,250,000 = \$325,000$ 1

Analysis: In this case, MassCode Inc. should elect the ASM, as it yields a credit $75,000 higher than the Traditional Method. The primary reason for this is the “Minimum Base Amount” rule in the Traditional Method, which penalized the company for its low historical R&D-to-revenue ratio. 2

Limitations on Applying the Credit: The 75% and Carryover Rules

Generating a credit is only the first step; applying it to the corporate excise involves several layers of limitation mandated by 830 CMR 63.38M.1(3) and (8).

The First $25,000 and the 75% Ceiling

The regulation establishes a unique “bracketed” limitation on credit use. A corporation is permitted to offset its excise tax dollar-for-dollar up to the first $25,000. 2 For any excise liability exceeding $25,000, the credit can only be used to offset 75% of that excess. 2

For example, if MassCode Inc. has a total tax liability of $225,000:

• First $25,000 is fully offset (Credit Used = $25,000).
• The remaining $200,000 is offset by 75% (Credit Used = $0.75 \times \$200,000 = \$150,000$).
• Total Credit Used = $175,000.
• The remaining $50,000 of excise must be paid in cash. 2

Carryover Lifespans

Massachusetts is generous with its carryover provisions, but they are categorized based on why the credit was not used:

1. 15-Year Carryover: Any portion of the credit that exceeds the taxpayer’s total excise for the year can be carried forward for 15 years. 2
2. Indefinite Carryover: Any portion of the credit that was disallowed specifically because of the 75% rule can be carried forward indefinitely. 2

This distinction is crucial for tax modeling. Credits that would have otherwise expired after 15 years are “saved” by the 75% rule, becoming permanent tax assets that remain on the balance sheet until fully utilized. 2

Aggregated Groups and Controlled Entities

Regulation 830 CMR 63.38M.1(7) and the proposed.2(9) mandate that members of a controlled group compute the research credit as a single entity. 1 This prevents large conglomerates from splitting their R&D and revenue among different subsidiaries to bypass the minimum base amount or the 75% rule.

The Aggregation Mechanism

A group first totals all QREs and basic research payments made by all members, eliminating any intercompany transactions (e.g., one subsidiary charging another for research services). 1 The group then calculates a single “aggregated credit.” 1 This credit is then allocated back to the individual members that are doing business in Massachusetts, typically based on each member’s share of the total Massachusetts QREs. 1

The $25,000 threshold for the 75% rule is also a group-wide limitation. 4 If a group has ten subsidiaries in Massachusetts, they do not each get a $25,000 offset; they must share a single $25,000 pool. 2

Specialized Sector Provisions: Life Sciences and Defense

The Massachusetts Research Credit includes specific carve-outs for industries deemed vital to the state’s strategic interest.

Certified Life Sciences Companies

Under the Life Sciences Tax Incentive Program, certified companies enjoy a rare exception to the non-refundability rule. 8 If a certified life sciences company has an unused research credit, it may opt to receive a refund of 90% of the credit balance. 8 This provision is a powerful tool for early-stage biotech firms that are investing heavily in R&D but have not yet achieved the profitability needed to generate a tax liability. 2 To qualify, companies must be engaged in life sciences R&D and meet job creation targets set by the Massachusetts Life Sciences Center. 8

Defense-Related Activities Election

Corporations engaged in defense-related activities can elect to calculate their research credit separately for those activities. 7 This includes research on arms, ammunition, and NASA equipment. 1 By making this election, a company with both commercial and defense divisions can isolate its defense QREs and their corresponding base amounts. 7 This is often advantageous if one division is growing rapidly while the other is stagnant, as it prevents a high base in one division from diluting the credit generated by the other. 7

Compliance and Documentation: The Audit Landscape

The Massachusetts Department of Revenue is known for rigorous audits of research credit claims. Regulation 830 CMR 63.38M.1(16) explicitly requires corporations to maintain “adequate records” to substantiate the calculation of the credit. 14

Critical Audit Points

• Wage Substantiation: Auditors often demand time-tracking data or project-specific logs to prove that employees were physically located in Massachusetts while performing research. 12
• The Four-Part Test: Companies must be prepared to show how a project met the federal definition of research. This includes technical white papers, design alternative assessments, and documentation of the uncertainties being resolved. 24
• Nexus Verification: For supply costs, the taxpayer must prove that the materials were used at a Massachusetts site. 5 For contract research, the taxpayer must verify that the contractor performed the work within the Commonwealth. 1
• Gross Receipts Accuracy: Under the Traditional Method, the definition of “gross receipts” must be consistent with the corporate excise apportionment rules, net of returns and allowances. 2

Failure to provide these records can lead to the “Inadequate Records” penalty, where the DOR defaults the corporation’s fixed-base ratio to the maximum 16%, significantly reducing or eliminating the credit. 1

Strategic Considerations for Business Blogs and Tax Planning

From a business planning perspective, the Massachusetts Research Credit is not a “set it and forget it” incentive. The choice of calculation method (Traditional vs. ASM) should be re-evaluated annually. 16

Key Takeaways for Financial Leaders

• The Power of the ASM: For high-growth companies, the ASM often provides a faster path to meaningful credits because it ignores revenue growth. However, for companies doing heavy academic collaboration, the 15% basic research “add-on” in the Traditional Method can be more valuable. 2
• Life Science Synergy: Life science firms should carefully track their MLSC certification status, as the 90% refundability transforms a deferred tax asset into immediate cash flow. 2
• Infinite Carryforwards: Finance teams should recognize that credits limited by the 75% rule effectively never expire. This allows for long-term tax planning that can span several business cycles. 2
• Financial Institution Opportunities: Following TIR 25-3, banks and other financial entities in Massachusetts should immediately review their prior-year R&D expenditures (such as software development for online banking platforms) to identify potentially millions of dollars in unclaimed credits. 6

Future Outlook: The Maturation of 830 CMR 63.38M.2

As of 2024, the Department of Revenue has expressed its intention to “repropose” 830 CMR 63.38M.2 to formally integrate the judicial rulings regarding financial institutions and to finalize the ASM procedures. 6 This will likely lead to a unified regulation that finally replaces the outdated 1991 framework. 6 Until then, taxpayers must continue to navigate the “proposed” guidance with the understanding that the DOR treats it as functionally binding. 14

The Massachusetts Research Credit remains one of the most effective tools for corporate tax mitigation in the New England region. By strictly tying the incentive to in-state activities and providing robust carryover options, the Commonwealth has created a system that rewards long-term commitment to the local innovation economy. 2

Conclusion

The regulatory environment defined by 830 CMR 63.38M.1 is complex, demanding a high degree of precision in both geographic tracking and financial calculation. Whether a company is a burgeoning biotech startup or a global financial giant, the ability to successfully claim the Massachusetts Research Credit hinges on a rigorous adherence to the “conducted in Massachusetts” requirement and a strategic selection of calculation methodologies. As administrative guidance continues to adapt to new business realities—such as remote work and the digital transformation of the banking sector—the credit will undoubtedly remain a vital instrument for any business looking to anchor its research and development operations in the Commonwealth. 2

R&D Tax Credit Preparation Services

Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.

If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.

R&D Tax Credit Audit Advisory Services

creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees—delivering robust, compliant support for R&D credit claims. Click here for more information about R&D tax credit management and implementation.

Our Fees

Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour. We are also able offer fixed fees and success fees in special circumstances. Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/